ES2137966T3 - Vehiculos para administracion oral de substancias farmaceuticamente activas inestables frente a los acidos. - Google Patents

Vehiculos para administracion oral de substancias farmaceuticamente activas inestables frente a los acidos.

Info

Publication number
ES2137966T3
ES2137966T3 ES93201612T ES93201612T ES2137966T3 ES 2137966 T3 ES2137966 T3 ES 2137966T3 ES 93201612 T ES93201612 T ES 93201612T ES 93201612 T ES93201612 T ES 93201612T ES 2137966 T3 ES2137966 T3 ES 2137966T3
Authority
ES
Spain
Prior art keywords
vehicles
oral administration
pharmaceutically active
substances against
against acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93201612T
Other languages
English (en)
Inventor
Kurt Lovgren
Ake Pilbrant
Mitsuru Yasumura
Satoshi Morigaki
Minoru Oda
Naohiro Ohishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB08610573A external-priority patent/GB2189699A/en
Application filed by Astra AB filed Critical Astra AB
Application granted granted Critical
Publication of ES2137966T3 publication Critical patent/ES2137966T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Abstract

MEJORAS EN LOS VEHICULOS PARA ADMINISTRACION ORAL DE SUSTANCIAS ACIDAS DEBILES FARMACOLOGICAMENTE ACTIVAS CON TENDENCIA A LA DECOLORACION, CONTENIENDO LA SUSTANCIA ACIDA DEBIL, EN DONDE EL VEHICULO DE ADMINISTRACION CONTIENE UN NUCLEO QUE CONTIENE DICHA SUSTANCIA JUNTO CON UN COMPUESTO DE REACCION ALCALINA O UNA SAL ALCALINA DE DICHA SUSTANCIA MEZCLADA OPCIONALMENTE CON UN COMPUESTO DE REACCION ALCALINA, ADOPTANDO LA FORMA DE UN NUMERO DE PEQUEÑAS PERLAS, FORMANDO OPCIONALMENTE PEQUEÑAS TABLETAS O UNA TABLETA TAL COMO LA QUE CONTIENE UNA CUBIERTA HECHA DE UNA O MAS CAPAS DE SUBCUBIERTAS DE REACCION INERTE CONTENIENDO TABLETAS EXCIPIENTES LAS CUALES SON SOLUBLES O RAPIDAMENTE DESINTEGRABLES EN AGUA, O POLIMEROS SOLUBLES EN AGUA, COMPUESTOS EN FORMA DE LAMINAS CONTENIENDO OPCIONALMENTE UN REDUCTOR DE PH, O BIEN CONTENIENDO COMPUESTOS ALCALINOS ENTRE EL NUCLEO DE REACCION ALCALINA Y UNA CAPA DE CUBIERTA ENTERICA EXTERIOR.
ES93201612T 1986-04-30 1987-04-16 Vehiculos para administracion oral de substancias farmaceuticamente activas inestables frente a los acidos. Expired - Lifetime ES2137966T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB08610573A GB2189699A (en) 1986-04-30 1986-04-30 Coated acid-labile medicaments
EP92107178A EP0502556B1 (en) 1986-04-30 1987-04-16 Use of specific core material and layers to obtain pharmaceutical formulations stable to discolouration of acid labile compounds

Publications (1)

Publication Number Publication Date
ES2137966T3 true ES2137966T3 (es) 2000-01-01

Family

ID=26130898

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93201612T Expired - Lifetime ES2137966T3 (es) 1986-04-30 1987-04-16 Vehiculos para administracion oral de substancias farmaceuticamente activas inestables frente a los acidos.

Country Status (2)

Country Link
ES (1) ES2137966T3 (es)
GR (1) GR3032639T3 (es)

Also Published As

Publication number Publication date
GR3032639T3 (en) 2000-06-30

Similar Documents

Publication Publication Date Title
ES2135443T3 (es) Vehiculo mejorado para la administracion oral de omeprazol.
ES2010648T3 (es) Formulaciones farmaceuticas de sustancias labiles frente a los acidos para uso oral.
ES2172239T3 (es) Sistema osmotico de liberacion de farmacos.
AR065827A2 (es) Formas de dosificacion de liberacion sostenida de sertralina, sales de sertralina, composicion farmaceutica, procedimiento y preparacion y su uso en terapia
MY102459A (en) Oral sustained release pharmaceutical preparation.
ATA131091A (de) Orale feste pharmazeutische dosierungsform mit programmierter wirkstofffreisetzung und verfahren zu ihrer herstellung
IT1245761B (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
SE9402431D0 (sv) New tablet formulation
ES2031491T3 (es) Tableta para uso farmaceutico capaz de liberar sustancias activas en momentos sucesivos.
ES2157975T3 (es) Soluciones farmaceuticas con solubilidad mejorada.
TNSN98229A1 (fr) Formulation pharmaceutique orale a liberation prolongee
PE71699A1 (es) Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
RU94045950A (ru) Фармацевтический препарат и способ его приготовления
DE69133623D1 (de) Haltende neue pharmazeutische formulierungen sowie verfahren zu deren herstellung
ES2125342T3 (es) Esteres y combinaciones de un nitrato organico y de un salicilato.
ES2053768T3 (es) Tabletas masticables.
ES2055775T3 (es) Nueva forma de dosificacion.
IE65251B1 (en) Controlled release capsules
HU9301672D0 (en) Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents
ES2137966T3 (es) Vehiculos para administracion oral de substancias farmaceuticamente activas inestables frente a los acidos.
AR003434A1 (es) Compuesto de tiludronato, composiciones farmaceuticas que los contienen y proceso para producir dicho compuesto y procedimiento para producir lascomposiciones farmaceuticas.
ES531346A0 (es) Procedimiento para producir una tableta de administracion oral de liberacion controlada, independiente del ph
LV11820A (lv) Karbamazepina arstnieciska forma ar paleninatu aktivas vielas izdalisanos
PT742716E (pt) Composicao farmaceutica para administracao transdermica sistemica contendo a substancia activa morfina-6-glucuronido

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 565210

Country of ref document: ES